Glial reactivity after antipsychotic treatment. An experimental study in rats and its implications for psychiatry.
BACKGROUND
The importance of the glial cells in the function of the nervous system and in its pathology has been the object of multiple studies in the last years. Specifically, their role in the action of the antipsychotics is debated. Our study has analyzed glial reactivity in rats treated with antipsychotics.


METHODS
In a first ultrastructural study of the arcuate nucleus of the hypothalamus, the animals were treated with chlorpromazine for 40 days, and were sacrificed at the end of the treatment, after 20 days of rest without treatment. In another series of studies, with the light microscope and immunohistochemistry we evaluated the immunoreactivity of the glial fibrillary acidic protein (GFAP) in six regions of the central nervous system of rats treated with typical and atypical antipsychotics.


RESULTS
With the electron microscope, the animals treated with chlorpromazine showed a significant reduction of the axosomatic synapses on the neurons of the hypothalamic arcuate nucleus and an increase of glial presence, as noted by the greater amount of astrocyte processes. The mentioned modifications were reversible, tending to normalize in a group of animals sacrificed 20 days after completion of the treatment. In the immunohistochemical study, the glial reaction was important in the territory of the nucleus accumbens with all the antipsychotics, moderate in the cingulate cortex, although only with atypical antipsychotics, and scarcely significant in the rest of the regions.


CONCLUSIONS
Our results confirm that the glial cells are targets of the antipsychotic action, and this will allow us to better understand the action of these drugs and the role of the glial cells in the normal function of the nervous system and in the mental disease.
Facultad de Medicina, Dpto de Anatomía e Histología Humanas, Avda Alfonso el Sabio s/n. 37007 Salamanca.
J L
JL
Blázquez Arroyo
E
E
Fraile Malmierca
A
A
Casadiego Cubides
G
G
Llorca Ramón
A
A
Ledesma Jimeno
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology*; D009457:Neuroglia / Q000187:drug effects* / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar
D014150:Antipsychotic Agents; D002746:Chlorpromazine